Protagonist Therapeutics Inc (NASDAQ:PTGX)

29.96
Delayed Data
As of Oct 20
 +0.27 / +0.91%
Today’s Change
12.80
Today|||52-Week Range
50.54
+48.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.0020.1M30.9M
 
 
 
Depreciation And Amortization247.0K317.0K406.0K527.0K
 
 
 
 
 
 
Operating ExpensesGross Income-247.0K-317.0K----
 
 
 
General Expenses14.5M32.3M57.6M72.7M
 
 
 
 
 
Research And Development11.8M25.7M46.2M59.5M
 
 
 
 
 
Total Operating Expenses14.8M32.7M58.0M73.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.8M-32.7M-37.9M-42.3M
 
 
 
 
 
Extraordinary Charge-83.0K-4.7M0.000.00
 
 
 
Other Expenses0.00-34.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.9M-37.2M-37.0M-39.7M
 
 
 
 
 
Income Taxes0.000.000.00-799.0K
 
 
Preferred Dividend-75.0K-558.0K0.000.00
 
 
 
Net Income-14.9M-37.2M-37.0M-38.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS17.4M6.5M17.7M22.4M
 
 
 
 
 
Shares To Calculate EPS Diluted17.4M6.5M17.7M22.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.86-$5.80-$2.09-$1.74
 
 
 
 
 
EPS Diluted-$0.86-$5.80-$2.09-$1.74